Merck Sues SmithKline Over Vaccine Rights
- Share via
Merck & Co. Inc., claiming exclusive rights to distribute a chicken pox vaccine in the United States and Canada, sued four affiliates of SmithKline Beecham in an effort to block them from distributing their vaccine in the United States. Named as defendants are SmithKline Beecham U.S. affiliates SKB Pharmaceuticals Co., SKB Holdings Corp., SKB Corp. and the Belgian affiliate SKB Biologicals. No one at SmithKline’s U.S. offices in Philadelphia could be reached for comment. SmithKline is based in London. Merck stock climbed 25 cents to $83.25 in abbreviated trading on the New York Stock Exchange. In the U.S., the chicken pox virus hospitalizes 10,000 people a year and kills about 100, court papers said.
More to Read
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
More From the Los Angeles Times
Podcasts
John Orr was a renowned fire investigator who was also a prolific arsonist, and whose thinly veiled novel helped to convict him. In this episode we hear from the fire captain who first suspected him—and from Orr himself.
Madison McGhee is joined by legendary Dateline host Josh Mankiewicz and esteemed L.A. Times Reporter Richard Winton as the three of them dive into all-things Menendez Brothers, the good, the bad, and the still unknown.
NPR climate editor Sadie Babits talks about why the media has long overlooked the climate crisis, and how that’s starting to change.
